Ignite Creation Date:
2024-05-06 @ 3:31 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04652609
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2020-10-20
Brief Title:
Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program
Sponsor:
Universidad de Granada
Organization:
Universidad de Granada
Study Overview
Official Title:
Prevention of Chemotherapy-induced Peripheral Neuropathy With Therapeutic Exercise and Blood Flow Restriction Using PRESIONA Program
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRESIONA
Brief Summary:
The aim of this study is to determinate if therapeutic exercise with blood flow restriction BFR during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy CIPN comparing to usual care
Detailed Description:
CIPN is a side effect of cancer therapies that nowadays has no solution so our intention is to carry out a preventive therapy against the onset of CIPN The nature of the studies that try to prevent is very diverse but one of the wide tools is therapeutic exercise In this case we intend to combine therapeutic exercise with BFR to obtain a pre-conditioning effect that protects intraepidermal fibers from exposure to the chemotherapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None